“IDENTIFICATION OF ENDOGENOUS SUPEROXIDE DISMUTASE AS A POTENTIAL INHIBITOR FOR PI3K/AKT SIGNALING IN COLORECTAL CANCER - A MOLECULAR DOCKING STUDY” (2022) Journal of Pharmaceutical Negative Results, pp. 1374–1379. doi:10.47750/pnr.2022.13.S03.214.